By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


MabVax Therapeutics, Inc. 

11588 Sorrento Valley Road
Suite 20
San Diego  California  92121  U.S.A
Phone: 858-259-9405 Fax:



Company News
MabVax Therapeutics, Inc. HuMab 5B1 Antibody Is Highlighted At Upcoming World Molecular Imaging Congress In Five Separate Presentations 8/31/2015 8:56:02 AM
MabVax Therapeutics, Inc. And The Rockefeller University Enter Into A Collaborative Research Agreement 8/6/2015 6:35:16 AM
MabVax Therapeutics, Inc. Issues Letter To Stockholders 8/5/2015 7:13:02 AM
MabVax Therapeutics Holdings To Present At The 2015 LD Micro Invitational Investor Conference On June 2nd At 4:30 PM EDT 5/28/2015 7:48:33 AM
MabVax Therapeutics, Inc.' Human Antibody Clinical Development Candidate HuMab 5B1 Successfully Clears Important Early Toxicology Testing 5/5/2015 6:28:22 AM
MabVax Therapeutics, Inc. Appoints Tom Varvaro To Its Board Of Directors 4/7/2015 9:45:01 AM
MabVax Therapeutics, Inc. Announces Closing Of Financing 4/6/2015 8:00:52 AM
MabVax Therapeutics, Inc. Enters Into Exchange Agreements To Issue Common Stock And Series D Preferred Stock Eliminating Series A-1 And B Convertible Preferred And Related Warrants 3/26/2015 6:23:04 AM
MabVax Therapeutics, Inc. To Present At The 27th Annual Roth Conference 3/3/2015 10:35:31 AM
MabVax Therapeutics, Inc. Selected To Present At 2015 Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/4/2015 11:16:22 AM